Alison A. Armour

Chief Medical Officer, ENDOCYTE INC.

Companies

Halozyme TherapeuticsSVP, Research & Development May 6, 2019 to Jun 4, 2019¹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARHalozyme Therapeutics, SVP, Research & Development